This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the potential of epicutaneous immunotherapy in toddlers with Peanut Allergy

Ticker(s): DBVT

Who's the expert?

Institution: Allergy and Asthma Center of Minnesota

  • Pediatric Allergist & Immunologist in private practice.
  • Manages over 1000 patients with asthma and 400 with peanut allergy.
  • Double Board certified in Pediatrics & Allergy, Asthma and Immunology; President of the Minnesota Allergy Society and director of Outpatient Allergy at the University of Minnesota.

Interview Goal
Discussing the potential of the Viaskin Peanut patch

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.